1. Home
  2. PVLA vs NWPX Comparison

PVLA vs NWPX Comparison

Compare PVLA & NWPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PVLA
  • NWPX
  • Stock Information
  • Founded
  • PVLA 2015
  • NWPX 1966
  • Country
  • PVLA United States
  • NWPX United States
  • Employees
  • PVLA N/A
  • NWPX N/A
  • Industry
  • PVLA Biotechnology: Pharmaceutical Preparations
  • NWPX Steel/Iron Ore
  • Sector
  • PVLA Health Care
  • NWPX Industrials
  • Exchange
  • PVLA Nasdaq
  • NWPX Nasdaq
  • Market Cap
  • PVLA 604.2M
  • NWPX 501.8M
  • IPO Year
  • PVLA N/A
  • NWPX 1995
  • Fundamental
  • Price
  • PVLA $65.78
  • NWPX $52.15
  • Analyst Decision
  • PVLA Strong Buy
  • NWPX Hold
  • Analyst Count
  • PVLA 12
  • NWPX 1
  • Target Price
  • PVLA $66.67
  • NWPX $55.00
  • AVG Volume (30 Days)
  • PVLA 179.9K
  • NWPX 67.4K
  • Earning Date
  • PVLA 11-15-2025
  • NWPX 10-29-2025
  • Dividend Yield
  • PVLA N/A
  • NWPX N/A
  • EPS Growth
  • PVLA N/A
  • NWPX 32.83
  • EPS
  • PVLA N/A
  • NWPX 3.32
  • Revenue
  • PVLA N/A
  • NWPX $499,125,000.00
  • Revenue This Year
  • PVLA N/A
  • NWPX $4.00
  • Revenue Next Year
  • PVLA N/A
  • NWPX $4.53
  • P/E Ratio
  • PVLA N/A
  • NWPX $15.71
  • Revenue Growth
  • PVLA N/A
  • NWPX 5.83
  • 52 Week Low
  • PVLA $11.17
  • NWPX $36.97
  • 52 Week High
  • PVLA $65.80
  • NWPX $57.76
  • Technical
  • Relative Strength Index (RSI)
  • PVLA 70.90
  • NWPX 51.93
  • Support Level
  • PVLA $60.49
  • NWPX $51.71
  • Resistance Level
  • PVLA $65.57
  • NWPX $53.80
  • Average True Range (ATR)
  • PVLA 3.63
  • NWPX 1.42
  • MACD
  • PVLA 0.19
  • NWPX -0.19
  • Stochastic Oscillator
  • PVLA 99.83
  • NWPX 36.07

About PVLA Palvella Therapeutics Inc. Common Stock

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

Share on Social Networks: